News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CSPC PHARMA (01093.HK) Paclitaxel for Injection Approved for Marketing
CSPC PHARMA (01093.HK) announced that Paclitaxel for Injection (Albumin-bound) (II) (100mg) developed by the group has been approved for marketing by the National Medical Products ...
Reset
Send
The window will close in 5 seconds
CSPC PHARMA (01093.HK) Paclitaxel for Injection Approved for Marketing
Close
Recommend
1
Positive
7
Negative
1
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

CSPC PHARMA (01093.HK)  -0.300 (-4.082%)    Short selling $144.63M; Ratio 25.379%   announced that Paclitaxel for Injection (Albumin-bound) (II) (100mg) developed by the group has been approved for marketing by the National Medical Products Administration, making it the world’s first fast-dissolving albumin-bound paclitaxel formulation.

The product is an innovative anti-tumor nano formulation independently developed by the group, adopting novel prescription and preparation technologies. Relevant patents have been granted in major countries including China, the US and Europe. Its indications include metastatic breast cancer after failure of combination chemotherapy or breast cancer that relapses within six months after adjuvant chemotherapy. (ha/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-15 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.